Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPACE: [18F]CETO PET/CT in Primary Aldosteronism
NCT06616142Phase 2Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2024
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of [18F]CETO in primary aldosteronism (PA), sponsored by University Medical Center Groningen. Started Nov 2024; status: recruiting.
02
Drugs
[18F]CETO
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NCT06616142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06616142.